Chiral Drugs. An Overview
International Journal of Biomedical Science · 15.09.2006 · 2 (2) · 85-100
DOI: 10.59566/ijbs.2006.2085 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biomedical Science, online erschienen am 15.09.2006. Verfasst von Pham-Huy Chuong und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1161-mal zitiert (Crossref).
Abstract (Originalsprache)
About more than half of the drugs currently in use are chiral compounds and near 90% of the last ones are marketed as racemates consisting of an equimolar mixture of two enantiomers. Although they have the same chemical structure, most isomers of chiral drugs exhibit marked differences in biological activities such as pharmacology, toxicology, pharmacokinetics, metabolism etc. Some mechanisms of these properties are also explained. Therefore, it is important to promote the chiral separation and analysis of racemic drugs in pharmaceutical industry as well as in clinic in order to eliminate the unwanted isomer from the preparation and to find an optimal treatment and a right therapeutic control for the patient. In this article, we review the nomenclature, pharmacology, toxicology, pharmacokinetics, metabolism etc of some usual chiral drugs as well as their mechanisms. Different techniques used for the chiral separation in pharmaceutical industry as well as in clinical analyses are also examined.
Zitieren
APA
Chuong, P., Nguyen, L. A., & He, H. (2006). Chiral Drugs. An Overview. International Journal of Biomedical Science, 2(2), 85-100. https://doi.org/10.59566/ijbs.2006.2085
Vancouver
Chuong P, Nguyen LA, He H. Chiral Drugs. An Overview. International Journal of Biomedical Science. 2006;2(2):85-100. doi:10.59566/ijbs.2006.2085
BibTeX
@article{Chuong2006,
author = {Chuong, Pham-Huy and Nguyen, Lien Ai and He, Hua},
title = {Chiral Drugs. An Overview},
journal = {International Journal of Biomedical Science},
year = {2006},
volume = {2},
number = {2},
pages = {85--100},
doi = {10.59566/ijbs.2006.2085}
}
EUVIMED